Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125530853 | 12553085 | 3 | F | 20160718 | 20160713 | 20160810 | PER | US-PFIZER INC-2016329035 | PFIZER | 65.00 | YR | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125530853 | 12553085 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Vaginal | 0.625 MG, UNK | Y | 20216 | .625 | MG | VAGINAL CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125530853 | 12553085 | 1 | Vulvovaginal dryness |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125530853 | 12553085 | Hypersensitivity | |
| 125530853 | 12553085 | Intentional product use issue | |
| 125530853 | 12553085 | Vulvovaginal burning sensation | |
| 125530853 | 12553085 | Vulvovaginal discomfort | |
| 125530853 | 12553085 | Vulvovaginal pain | |
| 125530853 | 12553085 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125530853 | 12553085 | 1 | 2016 | 20160629 | 0 |